APLS — Apellis Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Apellis Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	878	701	552	351	411
Net Total Accounts Receivable
Net Total Receivables	—	10.1	29.2	224	272
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	917	824	720	766	789
Net Property, Plant And Equipment	24.5	26.1	24.9	21.1	19
Other Long Term Assets
Total Assets	961	882	760	789	885
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	128	132	168	248	186
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	756	683	590	594	657
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	205	199	170	195	229
Total Liabilities & Shareholders' Equity	961	882	760	789	885
Total Common Shares Outstanding